Ionis Pharmaceuticals (United States)

2.3k papers and 140.7k indexed citations i.

About

In recent decades, authors affiliated with Ionis Pharmaceuticals (United States) have published 2.3k papers, which have received a total of 140.7k indexed citations. Scholars at this organization have produced 1.6k papers in Molecular Biology, 203 papers in Epidemiology and 198 papers in Genetics on the topics of DNA and Nucleic Acid Chemistry (556 papers), Advanced biosensing and bioanalysis techniques (405 papers) and RNA Interference and Gene Delivery (341 papers). Their work is cited by papers focused on Molecular Biology (95.9k citations), Cancer Research (21.4k citations) and Epidemiology (13.0k citations). Authors at Ionis Pharmaceuticals (United States) collaborate with scholars in United States, Canada and United Kingdom and have published in prestigious journals including Nature, Science and Cell. Some of Ionis Pharmaceuticals (United States)'s most productive authors include Stanley T. Crooke, C. Frank Bennett, Brett P. Monia, Susan M. Freier, Richard S. Geary, Eric E. Swayze, Nicholas M. Dean, Brenda F. Baker, Frank Rigo and Mark J. Graham.

In The Last Decade

Fields of papers published by authors at Ionis Pharmaceuticals (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Ionis Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Ionis Pharmaceuticals (United States) at the time of their publication.

Countries citing scholars working at Ionis Pharmaceuticals (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Ionis Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Ionis Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ionis Pharmaceuticals (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025